Literature DB >> 14643598

Geometrically structured implants for cranial reconstruction made of biodegradable polyesters and calcium phosphate/calcium carbonate.

Carsten Schiller1, Christian Rasche, Michael Wehmöller, Felix Beckmann, Harald Eufinger, Matthias Epple, Stephan Weihe.   

Abstract

The aim of this study was the development of a processing pathway for manufacturing of biodegradable skull implants with individual geometry. The implants on the basis of polylactide and calcium phosphate/calcium carbonate were prepared by a combination of hot pressing and gas foaming. On the inside, the implant consists of a macroporous and faster degradable material (poly(D,L-lactide)+CaCO3) to allow the ingrowth of bone cells. The pore size is in the range of 200-400 microm. On the outside, the implant consists of a compact and slower biodegradable material (poly(L-lactide) and calcium phosphate) to ensure mechanical stability and protection. To overcome problems like inflammatory reactions caused by acidic degradation products of polylactide, the polyester was combined with basic filling materials (calcium salts). The filler neutralises the lactic acid produced during polymer degradation and increases the bioactivity of the material. The stabilised pH was demonstrated by long-term in vitro pH studies. Over a time period of 250 d in demineralised water, the pH was in the physiological range. The in vitro biocompatibility was shown by cell cultures with human osteoblasts. A good proliferation of the cells was observed over the whole test period of 4 weeks.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14643598     DOI: 10.1016/j.biomaterials.2003.08.047

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  10 in total

Review 1.  Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications.

Authors:  Noam Eliaz; Noah Metoki
Journal:  Materials (Basel)       Date:  2017-03-24       Impact factor: 3.623

2.  Development of graded hydroxyapatite/CaCO(3) composite structures for bone ingrowth.

Authors:  F Heilmann; O C Standard; F A Müller; M Hoffman
Journal:  J Mater Sci Mater Med       Date:  2007-05-05       Impact factor: 3.896

Review 3.  Biocomposites and hybrid biomaterials based on calcium orthophosphates.

Authors:  Sergey V Dorozhkin
Journal:  Biomatter       Date:  2011 Jul-Sep

4.  Solvent free production of porous PDLLA/calcium carbonate composite scaffolds improves the release of bone growth factors.

Authors:  H Schliephake; M Vucak; J Boven; S Backhaus; T Annen; M Epple
Journal:  Oral Maxillofac Surg       Date:  2014-09-03

Review 5.  Calcium Orthophosphate-Containing Biocomposites and Hybrid Biomaterials for Biomedical Applications.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2015-08-07

6.  A strut graft substitute consisting of a metal core and a polymer surface.

Authors:  Ana L C Lagoa; Christian Wedemeyer; Marius von Knoch; Franz Löer; Matthias Epple
Journal:  J Mater Sci Mater Med       Date:  2007-07-03       Impact factor: 3.896

7.  Biomaterials in skull base surgery.

Authors:  Wolfgang Maier
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-03-10

Review 8.  Application of bone growth factors--the potential of different carrier systems.

Authors:  Henning Schliephake
Journal:  Oral Maxillofac Surg       Date:  2010-03

9.  Effect of Injection Molding Melt Temperatures on PLGA Craniofacial Plate Properties during In Vitro Degradation.

Authors:  Liliane Pimenta de Melo; Gean Vitor Salmoria; Eduardo Alberto Fancello; Carlos Rodrigo de Mello Roesler
Journal:  Int J Biomater       Date:  2017-09-06

10.  Synthesis and characterization of PLGA/HAP scaffolds with DNA-functionalised calcium phosphate nanoparticles for bone tissue engineering.

Authors:  Viktoriya Sokolova; Kathrin Kostka; K T Shalumon; Oleg Prymak; Jyh-Ping Chen; Matthias Epple
Journal:  J Mater Sci Mater Med       Date:  2020-11-02       Impact factor: 3.896

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.